Evidence map›Paper›PMID 39651143›Full record

ArticlebioRxiv : the preprint server for biology2024

Raver1 links

Boyao Zhang, Pontus Orning, Jesse W Lehman, Alexandre Dinis, Leslie Torres-Ulloa, Roland Elling, Michelle A Kelliher, John Bertin, Megan K Proulx, Liv Ryan and 5 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Pontus Orning
Jesse W Lehman
Alexandre Dinis
Leslie Torres-Ulloa
Michelle A Kelliher
John Bertin
Megan K Proulx
Liv Ryan
Richard Kandasamy
Terje Espevik
Athma A Pai
Katherine A Fitzgerald
Egil Lien

Funding

Caspase-8 as a focal hub in effector-triggered immunityR01AI146855 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LIEN, EGIL · 2019 to 2023
$2.9M
RNA splicing factor Raver1 controls cell death, inflammation, and innateimmunityR01AI181309 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Egil Lien · 2024 to 2026
$2.5M
NIAID NIH HHS R01 AI146855NIAID NIH HHS R01 AI181309
6 · The paper itself

Abstract

Multiple cell death and inflammatory signaling pathways converge on two critical factors: receptor interacting serine/threonine kinase 1 (RIPK1) and caspase-8. Careful regulation of these molecules is critical to control apoptosis, pyroptosis and inflammation. Here we discovered a pivotal role of Raver1 as an essential regulator of Significance: Caspase-8 and the kinase RIPK1 are at focal points of several inflammation and cell death pathways. Thus, a careful regulation of their actions is needed. Our work identifies the RNA splicing factor Raver1 as a critical factor directing the splicing of

Identifiers

PMID39651143
PMCPMC11623576

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.